Gene: GFOD2
Official Full Name: Gfo/Idh/MocA-like oxidoreductase domain containing 2provided by HGNC
Gene Summary: Predicted to enable nucleotide binding activity and oxidoreductase activity. Predicted to be involved in extracellular matrix organization. Predicted to be located in extracellular region. Predicted to be active in extracellular matrix. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25725 | GFOD2 Knockout cell line (HeLa) | Human | GFOD2 | 1:3~1:6 | Negative | Online Inquiry |
KO25726 | GFOD2 Knockout cell line (HCT 116) | Human | GFOD2 | 1:2~1:4 | Negative | Online Inquiry |
KO25727 | GFOD2 Knockout cell line (HEK293) | Human | GFOD2 | 1:3~1:6 | Negative | Online Inquiry |
KO25728 | GFOD2 Knockout cell line (A549) | Human | GFOD2 | 1:3~1:4 | Negative | Online Inquiry |
GFOD2 Gene Knockout Cell Lines represent a pivotal tool in the field of molecular biology and genetics, designed specifically for research involving the GFOD2 gene, which is linked to various cellular processes including nucleotide metabolism and DNA repair mechanisms. These cell lines have been engineered to have the GFOD2 gene inactivated, allowing researchers to explore the functional consequences of its absence in a controlled environment.
The primary mechanism of action for GFOD2 Gene Knockout Cell Lines involves the targeted deletion of the GFOD2 gene through CRISPR/Cas9 technology or RNA interference (RNAi), which disrupts the normal protein expression and thereby elucidates the gene's role in critical cellular functions. By studying these knockout models, scientists can gain invaluable insights into disease pathways, particularly those related to cancer, neurodegenerative disorders, and metabolic syndromes.
The scientific importance of GFOD2 Gene Knockout Cell Lines is manifold, with applications ranging from basic research to clinical studies. They enable the investigation of gene function, validation of drug targets, and the development of novel therapeutic strategies. Moreover, these cell lines provide a reliable and reproducible means to analyze cellular response mechanisms in various experimental settings, contributing to advancements in precision medicine.
What sets GFOD2 Gene Knockout Cell Lines apart from alternative products is their high specificity and reliability. Unlike other cell lines that may yield ambiguous results due to off-target effects, our knockout models ensure precise gene disruption. Additionally, these cell lines are derived from robust lab standards, ensuring consistency across experiments.
For researchers and clinicians, GFOD2 Gene Knockout Cell Lines offer significant value by facilitating a deeper understanding of gene function and highlighting potential therapeutic targets. Their application can accelerate the transition from bench to bedside, making them integral for innovative research outcomes.
Our company is dedicated to providing high-quality biological products that empower researchers and drive scientific discovery. With our expertise in gene editing technologies and commitment to excellence, we stand as a trusted partner in the advancement of genetic research and therapeutic development.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.